This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Here's What Google Is Working on Next

Stocks in this article: GOOG INTC

NEW YORK (TheStreet) -- Google (GOOG) announced last week it was working on a smart contact lens, trying to help people with diabetes by measuring glucose levels in tears using a wireless chip. Sounds pretty futuristic, huh? Not at all, if you know anything about physics.

Google has been pretty busy lately, with its own projects and acquiring those of others. The company is working on driverless cars and Google Glass, and recently announced it was buying Nest, the smart smoke alarm and thermostat company, for $3.2 billion in cash.

In Physics of the Future, author Michio Kaku maps out some of the these things. To give away the book would do it a disservice, but I can tell you that Kaku predicted that glasses and contact lenses would be connected to the Internet. He also predicted cars would become driverless, all projects Google already is working on.  (Disclosure: I've read Physics of the Future for my own knowledge, but haven't reviewed it).

Google is working on these plans via Google X, the company's secret facility led by Google's co-founder Sergey Brin that works on top-secret projects. Google noted that it's in talks with the Food and Drug Administration on the contact lens project and there's plenty of more work to do, both from Google and others.

"We're not going to do this alone: We plan to look for partners who are experts in bringing products like this to market," the company said in a blog post. The company also said Google X seeks "... out projects that seem a bit speculative or strange, and at a time when the International Diabetes Federation (PDF) is declaring that the world is 'losing the battle' against diabetes, we thought this project was worth a shot."

Though Google is garnering lots of publicity surrounding the smart contact lens, it's not the only company to have worked on one. Microsoft (MSFT) worked on a functional contact lens a couple of years ago. Babak Parviz, the co-founder of Google's smart contact lens initiative, worked on the same project for Microsoft.



There are other companies that have tried to approach the non-invasive glucose monitoring market, to no avail.  Fovioptics, worked on something similar, developing
a non-invasive glucose monitor that read blood glucose level by shining a light into a patient's eye. Ultimately, the company decided there was no market for this, shut down, and returned money to investors.

Even if Google is successful, it's going to be expensive, notes David Kliff, publisher of the Diabetic Investor newsletter. "I can't imagine the regulatory mess from this," Kliff said in a phone interview. "Even if you can get it to work, which by no means is a certainty, the regulatory path is at least two years, maybe longer."

With the advent of the microchip, technology has become faster, more powerful and cheaper, due primarily to Moore's Law. Moore's Law, which comes from Intel's (INTC) co-founder Gordon Moore, states that the the number of transistors on circuits will double approximately every two years, making technology more powerful than it was just a few short years ago.

Interestingly enough, Kaku noted that eventually chips will cease to continue doubling in power, due to the nature of Moore's Law. But that's still years away.

Google X, much to no one's surprise, could not be reached for this story.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,086.82 +56.61 0.31%
S&P 500 2,091.60 +9.72 0.47%
NASDAQ 4,810.5840 +37.1120 0.78%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs